Can-Fite BioPharma Ltd.

Foreign Filer Report • Aug 31, 2023

_________ false

��-���� ������� ��"�	2 379
CAN-FITE BIOPHARMA LTD
Corporation no: 512022153	14960
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	31/08/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-101514	Time of broadcast: 13:05 13:05

---

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onFinancial results for the six months ended June 30, 2023 and updates on its drug development programs and an unaudited interim condensed consolidated financial statements as of June 30, 2023.

ea184381-6k_canfitebioEDGAR5_Bannerless_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 08/08/2023
Address: Bareket 10 , Petach-Tikva 47190   , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378
E-mail address: motti@canfite.co.il   Company site: www.canfite.com
Previous names of reporting entity:
Name of the Signatory: FARBSTEIN MORDECHAI Position of Signatory in the reporting corporation: Chief Operating Officer & CFO Name of Employer Company:
Address: Maharal street 10 , Tel Aviv 6248110 Telephone: 052-8998671 Facsimile: E-mail: Motti@canfite.co.il 1